儿童瘤组2023年研究蓝图:发育治疗学
Elizabeth Fox1, D Williams Parsons2, Brenda J Weigel3
1St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pediatric blood & cancer
|July 11, 2023
概括
发育治疗学委员会 (DVL) 通过评估向疗法和生物标志物选择的药物来推进儿童癌症治疗. 目前正在进行的研究重点是新的组合,以改善患有癌症的儿童和青少年的结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 翻译研究是翻译研究.
- 临床试验 临床试验
背景情况:
- 发育治疗委员会 (DVL) 专注于识别和开发新的治疗药物和治疗儿童和青少年癌症的治疗策略.
- 该委员会的研究已经从广泛的基于组织学的试验演变为更精确的生物标志物选择的第二阶段研究.
研究的目的:
- 评估针对儿童癌症的向疗法的活性.
- 通过临床和转化研究,推进对患有癌症的儿童和青少年的新药和治疗策略的开发.
主要方法:
- 在各种疾病队列中进行了单剂研究,评估向药物如卡博桑提尼布,特拉美提尼布和拉罗特雷克提尼布.
- 实施了生物标志物选择的第二阶段试验,包括儿科治疗选择分子分析 (MATCH) 研究,以针对特定的儿科瘤.
主要成果:
- 在多种疾病和特定疾病的队列中成功评估了多种向药物.
- 儿科MATCH研究使用了多种单一药物用于生物标志物选择的儿科瘤,证明了有针对性的方法.
结论:
- 在儿童癌症中,DVL已成功过渡到生物标志物选择的试验设计,以评估儿童癌症的向治疗.
- 委员会正在进行的努力旨在支持开发新型药物和组合,以改善患有癌症的儿童的护理.
相关概念视频
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

